GENE 0.8 (-27.93%)
SE0000661613Medical Diagnostics & ResearchDiagnostics & Research

Genetic Technologies (GENE) Competitor Comparison

We are evaluating the key criteria listed to compare Genetic Technologies (GENE) against its competitors in the Diagnostics & Research industry.

Performance 10 years - GENE ranking 0 / 58

These are the competitors of Genetic Technologies in the industry Diagnostics & Research ranked by performance 10 years
1. Lantheus Holdings LNTH
1.92K
2. Heska HSKA
1.65K
3. Medpace Holdings MEDP
1.47K
4. DexCom DXCM
1.13K
5. RadNet RDNT
918.41
6. IDEXX Laboratories IDXX
632.37
7. Icon ICLR
611.63
8. Natera NTRA
520
9. Mettler-Toledo MTD
436.49
10. Danaher DHR
366.09
11. Thermo Fisher Scientific TMO
360.97
12. Twist Bioscience TWST
311.08
13. Charles River Laboratories CRL
306.98
14. IQVIA Holdings IQV
304.64
15. NeoGenomics NEO
249.65
16. PerkinElmer PKI
247.07
17. Agilent Technologies A
224.77
18. Waters WAT
192.2
19. Exact Sciences EXAS
177.44
20. Quest Diagnostics DGX
141.55
21. Laboratory Corp of America Holdings LH
127.91
22. Fulgent Genetics FLGT
127.47
23. Syneos Health SYNH
113.83
24. National Research NRC
68.48
25. CareDx CDNA
67.47
26. Qiagen QGEN
63.75
27. Meridian Bioscience VIVO
60.69
28. Ortho Clinical Diagnostics Holdings OCDX
13.74
29. Guardant Health GH
11.96
30. Neogen NEOG
1.99
31. Inotiv NOTV
-8.54
32. Olink Holding OLK
-26.82
33. Myriad Genetics MYGN
-31
34. Illumina ILMN
-35.14
35. Sotera Health SHC
-54.22
36. Bioventus BVS
-56.62
37. Anixa Biosciences ANIX
-57.38
38. Sera Prognostics SERA
-57.76
39. DarioHealth DRIO
-61.87
40. Global Cord Blood CO
-66.57
41. bioAffinity Technologies BIAF
-69.52
42. Pacific Biosciences of California PACB
-70.83
43. MaxCyte MXCT
-73.57
44. MDxHealth MDXH
-77.04
45. Co-Diagnostics CODX
-77.5
46. Enzo Biochem ENZ
-78.07
47. Psychemedics PMD
-83.27
48. Trinity Biotech TRIB
-85.96
49. Biodesix BDSX
-87.56
50. Exagen XGN
-88.51
51. Neuronetics STIM
-92.52
52. Personalis PSNL
-92.97
53. Prenetics Global PRE
-94.37
54. SeqLL SQL
-95.1
55. Aspira Womens Health AWH
-97.44
56. Organovo Holdings ONVO
-99.26
57. Interpace Biosciences IDXG
-99.73
58. Precipio PRPO
-99.82

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.